Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 157

1.

Natriuretic peptides in the prognosis and management of acute coronary syndromes.

de Lemos JA, Peacock WF, McCullough PA.

Rev Cardiovasc Med. 2010;11 Suppl 2:S24-34. Review.

PMID:
20700099
2.

An evidence-based algorithm for the use of B-type natriuretic testing in acute coronary syndromes.

McCullough PA, Peacock WF, O'Neil B, de Lemos JA, Lepor NE, Berkowitz R.

Rev Cardiovasc Med. 2010;11 Suppl 2:S51-65. Review.

PMID:
20700103
3.

N-terminal B-type natriuretic peptide assessment provides incremental prognostic information in patients with acute coronary syndromes and normal troponin T values upon admission.

Weber M, Bazzino O, Navarro Estrada JL, Fuselli JJ, Botto F, Perez de Arenaza D, Möllmann H, Nef HN, Elsässer A, Hamm CW.

J Am Coll Cardiol. 2008 Mar 25;51(12):1188-95. doi: 10.1016/j.jacc.2007.11.054.

4.

Time to treatment and acute coronary syndromes: bridging the gap in rapid decision making.

Peacock WF.

Rev Cardiovasc Med. 2010;11 Suppl 2:S45-50. Review.

PMID:
20700102
5.

[Safe diagnosis in acute phase with T-proBNP. Heart failure and acute coronary syndrome can be identified very early].

Javadzadeh J, Collén AC, Manhem K, Swedberg K.

Lakartidningen. 2008 Feb 27-Mar 4;105(9):616-9. Swedish. No abstract available.

PMID:
18376704
6.

BNP: not just for heart failure.

Nicholls MG, Frampton CM, Yandle TG.

Heart. 2008 Jan;94(1):6-7. No abstract available.

PMID:
18083945
7.

B-type natriuretic peptides in acute coronary syndromes: implications in an aging population.

Krim SR, Vivo RP, de Lemos JA.

Clin Cardiol. 2012 Nov;35(11):682-5. doi: 10.1002/clc.22035. Epub 2012 Jul 3. Review.

8.

Analysis of N-terminal pro-B-type natriuretic peptide in patients with acute coronary syndromes.

Coppola G, Corrado E, Mulè MC, Augugliaro S, Cucchiara A, Novo G, Amoroso G, Assennato P, Hoffmann E, Vitale F, Novo S.

Coron Artery Dis. 2009 May;20(3):225-9. doi: 10.1097/MCA.0b013e32832a19a1.

PMID:
19387249
9.

Does admission NT-proBNP increase the prognostic accuracy of GRACE risk score in the prediction of short-term mortality after acute coronary syndromes?

Timóteo AT, Toste A, Ramos R, Miranda F, Ferreira ML, Oliveira JA, Ferreira RC.

Acute Card Care. 2009;11(4):236-42. doi: 10.1080/17482940903177036.

PMID:
19742352
10.

Emerging cardiac markers in coronary disease: role of brain natriuretic peptide and other biomarkers.

Palazzuoli A, Iovine F, Gallotta M, Nuti R.

Minerva Cardioangiol. 2007 Aug;55(4):491-6. Review.

PMID:
17653025
11.

Capturing the pathophysiology of acute coronary syndromes with circulating biomarkers.

McCullough PA, Peacock WF, O'Neil B, de Lemos JA.

Rev Cardiovasc Med. 2010;11 Suppl 2:S3-12.

PMID:
20700100
12.

B-type natriuretic peptides: prognostic markers in stable coronary artery disease.

Omland T.

Expert Rev Mol Diagn. 2008 Mar;8(2):217-25. doi: 10.1586/14737159.8.2.217. Review.

PMID:
18366308
13.

Sorting through new biomarkers.

Wood FO, de Lemos JA.

Curr Cardiol Rep. 2008 Jul;10(4):319-26.

PMID:
18611367
14.

Circulating natriuretic peptide levels in acute heart failure.

Maisel A.

Rev Cardiovasc Med. 2007;8 Suppl 5:S13-21. Review.

PMID:
18192949
15.

Biomarkers in clinical practice.

Alpert JS.

Am J Med. 2011 Aug;124(8):677-8. doi: 10.1016/j.amjmed.2011.04.006. Epub 2011 Jun 16. No abstract available.

PMID:
21683327
16.

[Natriuretic peptides and multimarker approach to risk stratification of patients with acute coronary syndromes].

Matunović R, Stojanović A, Mijailović Z, Cosić Z.

Med Pregl. 2006 May-Jun;59(5-6):248-52. Review. Serbian.

PMID:
17039908
17.

Serial bedside B-type natriuretic peptide strongly predicts prognosis in acute coronary syndrome independent of echocardiographic abnormalities.

Ang DS, Kong CF, Kao MP, Struthers AD.

Am Heart J. 2009 Jul;158(1):133-40. doi: 10.1016/j.ahj.2009.04.024.

PMID:
19540403
18.

Prognostic value of biomarkers during and after non-ST-segment elevation acute coronary syndrome.

Eggers KM, Lagerqvist B, Venge P, Wallentin L, Lindahl B.

J Am Coll Cardiol. 2009 Jul 21;54(4):357-64. doi: 10.1016/j.jacc.2009.03.056.

19.

Additive prognostic value of NT-proBNP over TIMI risk score in intermediate-risk patients with acute coronary syndrome.

Eren NK, Ertaş F, Yüksek U, Cakir C, Nazli C, Köseoğlu M, Ergene O.

Turk Kardiyol Dern Ars. 2009 Jan;37(1):1-8.

20.

Improving long-term risk prediction in patients with acute chest pain: the Global Registry of Acute Coronary Events (GRACE) risk score is enhanced by selected nonnecrosis biomarkers.

Eggers KM, Kempf T, Venge P, Wallentin L, Wollert KC, Lindahl B.

Am Heart J. 2010 Jul;160(1):88-94. doi: 10.1016/j.ahj.2010.05.002.

PMID:
20598977

Supplemental Content

Support Center